https://fakpathway.com/a-a-sma....ller-amount-ideal-un
Our present study aimed to explore the worthiness of RDW in NSCLC clients. A total of 338 NSCLC patients, 109 small cellular lung disease (SCLC) patients, and 302 healthy members had been retrospectively analyzed between January 2016 and December 2018. In today's study, we discovered that RDW had been substantially increased in NSCLC patients. Receiver-operating attribute (ROC) evaluation showed that the location beneath the ROC curve (AUC) of RDW was 0.753 in discriminating NSCLC patients from healthy participants, the suita
Like
Comment
Share
